Gross profit · 2015–2025

AstraZeneca gross profit

$48.1B+9.7% · FY2025

AstraZeneca (AZN) reported $48.1B in gross profit for fiscal 2025, +9.7% year on year.

$20.1B2015$18.9B2016$18.1B2017$17.2B2018$19.5B2019$21.3B2020$25.0B2021$32.0B2022$37.5B2023$43.9B2024$48.1B2025
AstraZeneca — Gross profit, 2015–2025
Fiscal yearGross profitChangeFiling
FY20252025-12-31$48.1B+9.7%Open →
FY20242024-12-31$43.9B+16.8%Open →
FY20232023-12-31$37.5B+17.5%Open →
FY20222022-12-31$32.0B+27.9%Open →
FY20212021-12-31$25.0B+17.2%Open →
FY20202020-12-31$21.3B+9.5%Open →
FY20192019-12-31$19.5B+13.5%Open →
FY20182018-12-31$17.2B−5.5%Open →
FY20172017-12-31$18.1B−3.9%Open →
FY20162016-12-31$18.9B−5.9%Open →
FY20152015-12-31$20.1B—Open →

Gross profit — Gross profit is revenue minus the direct cost of goods and services sold. Not every company reports it; those that do not are absent from this ranking.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2015–2025 compound annual growth +9.1%

Figures are reported under IFRS, in US dollars.

Gross profit at companies of similar size

Full ranking by gross profit →

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=AstraZeneca gross profit |url=https://companiesranked.com/en/company/astrazeneca/gross-profit |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). AstraZeneca gross profit. CompaniesRanked. https://companiesranked.com/en/company/astrazeneca/gross-profit

BibTeX

@misc{companiesranked-en-company-astrazeneca-gross-profit-2026,
  author       = {{CompaniesRanked}},
  title        = {{AstraZeneca gross profit}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/astrazeneca/gross-profit}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 20-F · 0001104659-26-019130 · February 24, 2026

{{cite web |title=AstraZeneca gross profit — 20-F (0001104659-26-019130) |url=https://www.sec.gov/Archives/edgar/data/901832/000110465926019130/azn-20251231x20f.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-24}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← AstraZeneca overview